Search

Your search keyword '"Hamm C"' showing total 1,727 results
Start Over Author "Hamm C"
1,727 results on '"Hamm C"'

124. Positionspapier zur Statintherapie

Author

Böhm, M., Laufs, U., Hamm, C., Andresen, D., Becker, H.-J., Borggrefe, M., Brachmann, J., Dietz, R., Ertl, G., Fleck, E., Gottwik, M.G., de Haan, F., Hoffmeister, H.M., Heusch, G., Meinertz, T., Osterspey, A., Silber, S., and Trappe, H.-J.

Published
2007
Full Text
View/download PDF

125. The association of body mass index with long-term clinical outcomes after ticagrelor monotherapy following abbreviated dual antiplatelet therapy in patients undergoing percutaneous coronary intervention : a prespecified sub-analysis of the GLOBAL LEADERS trial

Author

Ono, M., Chichareon, P., Tomaniak, M., Kawashima, H., Takahashi, K., Kogame, N., Modolo, R., Hara, H., Gao, C., Wang, R., Walsh, S., Suryapranata, H., da Silva, P.C., Cotton, J., Koning, R., Akin, I., Rensing, B.J.W.M., Garg, S., Wykrzykowska, J.J., Piek, J.J., Jüni, P., Hamm, C., Steg, P.G., Valgimigli, M., Windecker, S., Storey, R.F., Onuma, Y., Vranckx, P., and Serruys, P.W.

Abstract

Background\ud \ud The efficacy of antiplatelet therapies following percutaneous coronary intervention (PCI) may be affected by body mass index (BMI).\ud \ud \ud \ud Methods and results\ud \ud This is a prespecified subgroup analysis of the GLOBAL LEADERS trial, a prospective, multicenter, open-label, randomized controlled trial in an all-comer population undergoing PCI, comparing the experimental strategy (23-month ticagrelor monotherapy following 1-month dual antiplatelet therapy [DAPT]) with a reference regimen (12-month aspirin monotherapy following 12-month DAPT). A total of 15,968 patients were stratified by baseline BMI with prespecified threshold of 27 kg/m2. Of those, 6973 (43.7%) patients with a BMI

Published
2020

126. Lebensqualität von KHK-Patienten nach Implantation eines bioresorbierbaren Stents (ABSORB™) – Ergebnisse des GABI-R-Registers

Author

Pahmeier, K, Neusser, S, Hamm, C, Kastner, J, Wöhrle, J, Zahn, R, Achenbach, S, Mehilli, J, Gori, T, Naber, C, Nef, H, Neumann, T, Richardt, G, Schmermund, A, Claas, C, Riemer, T, and Biermann-Stallwitz, J

Subjects
ddc: 610, 610 Medical sciences, Medicine
Abstract

Hintergrund: Herz-Kreislauf-Erkrankungen, insbesondere die Koronare Herzkrankheit (KHK), zählen in Industrienationen zu den häufigsten Todesursachen. Bei der Behandlung der KHK stellen vollresorbierbare Stents eine der jüngsten Weiterentwicklungen dar. Im Unterschied zur Therapie mit [zum vollständigen Text gelangen Sie über die oben angegebene URL], 18. Deutscher Kongress für Versorgungsforschung (DKVF)

Published
2019
Full Text
View/download PDF

140. Ticagrelor monotherapy beyond 1 month versus standard dual antiplatelet therapy after drug-eluting coronary stenting: a pre-specified per-protocol analysis of the GLOBAL LEADERS trial

Author

Gragnano, F, primary, Zwahlen, M, additional, Vranckx, P, additional, Juni, P, additional, Heg, D, additional, Hamm, C, additional, Steg, P.G, additional, Hagenbuch, N, additional, Gargiulo, G, additional, Van Geuns, R.J, additional, Huber, K, additional, Van Amsterdam, R, additional, Serruys, P.W, additional, Valgimigli, M, additional, and Windecker, S, additional

Published
2020
Full Text
View/download PDF

146. Leitlinien zur Einrichtung und zum Betreiben von Herzkatheterräumen (1.Neufassung) Herausgegeben vom Vorstand der Deutschen Gesellschaft für Kardiologie – Herz- und Kreislaufforschung Bearbeitet im Auftrag der Kommission für Klinische Kardiologie: Herausgegeben vom Vorstand der Deutschen Gesellschaft für Kardiologie – Herz- und Kreislaufforschung Bearbeitet im Auftrag der Kommission für Klinische Kardiologie

Author

Hamm, C. W., Bösenberg, H., Brennecke, R., Daschner, F., Dziekan, G., Erbel, R., Ewen, K., Geffers, C., Hausdorf, G., Kelm, M., Rüden, H., Sauer, G., Strauer, B., and für die Kommission Klinische Kardiologie

Published
2001
Full Text
View/download PDF

147. Gene expression analysis of MAOA and the clock gene ARNTL in individuals with bipolar disorder compared to healthy controls.

Author

Bengesser, S. A., Hohenberger, H., Tropper, B., Dalkner, N., Birner, A., Fellendorf, F. T., Platzer, M., Rieger, A., Maget, A., Hamm, C., Queissner, R., Pilz, R., Bauer, K., Lenger, M., Mörkl, S., Wagner-Skacel, J., Kapfhammer, H. P., Meier-Allard, N., Stracke, A., and Holasek, S. J.

Subjects
CIRCADIAN rhythms, MOLECULAR clock, GENE expression, BIPOLAR disorder, MONONUCLEAR leukocytes, BODY mass index
Abstract

Circadian rhythms are associated with bipolar disorder (BD). This cross-sectional study aimed at investigating ARNTL and MAOA gene expression differences (1) between individuals with BD and controls, (2) between affective episodes, and (3) the relationship between ARNTL and MAOA expression. ARNTL and MAOA gene expression in peripheral mononuclear blood cells were analysed from fasting blood samples (BD n = 81, controls n = 54) with quantitative real-time PCR operating on TaqMan® assays (normalised to 18S RNA expression). ANCOVAs corrected for age, sex, body mass index, and medication was used to evaluate expression differences and correlation analyses for the relation between ARNTL and MAOA expression. ARNTL gene expression differed between affective episodes (F(2,78) = 3.198, p = 0.047, Partial Eta2= 0.083), but not between BD and controls (n.s.). ARNTL and MAOA expression correlated positively in BD (r = 0.704, p < 0.001) and in controls (r = 0.932, p < 0.001). MAOA expression differed neither between BD and controls nor between affective episodes (n.s.). Clock gene expression changes were observed in different affective states of BD. More precisely, ARNTL gene expression was significantly higher in euthymia than in depression. ARNTL and MAOA gene expression correlated significantly in BD and in controls, which emphasises the strong concatenation between circadian rhythms and neurotransmitter breakdown. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results